RepliCel Life Sciences Inc (TSXV:RP)
RepliCel is a regenerative medicine company developing autologous cell therapies that address diseases caused by a deficit of healthy cells required for normal healing and function.
Imsight Medical, a Shenzhen-Hong Kong start-up developing an AI-assisted medical imaging analysis program, raised $3 million in a Series A round from Lenovo Capital and Incubator Group. Founded in early 2017, Imsight’s products combine image analysis and AI to automate medical image reading. The program completes the initial image read with 90% accuracy, says Imsight/ The reading is then reviewed by a doctor. Imsight, which was developed in Lenovo Capital’s incubator, cooperates with Lenovo Group’s big data and smart healthcare initiatives.
Source: ChinaBio Today
